Serr I, Furst RW, Achenbach P, et al. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice. Nat Commun 2016;7:10991Serr I, Fiirst RW, Achenbach P, et al. Type 1 diabetes vaccine candidates promote human Foxp3 + Treg induction in hmnanized mice[...
Type 1 Diabetes Vaccine Shows Promise In Small TrialmntScience Translational Medicine
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunotherapy that targets T cells as a means to de...
3) type 1 diabetes 1型糖尿病 1. Development of pathogenesis of idiopathic type 1 diabetes mellitus; 特发性1型糖尿病的发病机制进展 2. Effect of Family Nursing Interferences on Life Quality of Patients with Type 1 Diabetes; 家庭护理干预对1型糖尿病患者生活质量的影响 3. Characteristic of ...
This may explain why diabetes is less common among breastfed children. The MMR vaccine may also prevent some diabetes, in that diabetes tends to be more common following outbreaks of mumps or rubella. Related concepts: Diabetes mellitus – type I Last medical review on: January 07, 2014 Ask ...
1 Diabetes In Mice Novel Nanoparticle Vaccine Cures Type 1 Diabetes In MiceNovel Nanoparticle Vaccine Cures Type 1 Diabetes In MiceJoana CasasImmunity
A number of avenues are worthy of future research in the development of a Type 1 diabetes (T1D) vaccine. For example, recent research has shown that C-peptide levels of above 0.2 nmol/l stimulated by very limited nrys-cell function may reduce the long-term complications associated with T1...
Prospects of a type 1 diabetes vaccine 来自 国家科技图书文献中心 喜欢 0 阅读量: 17 作者:DP Cook,C Gysemans,C Mathieu 摘要: Pandemrix inducing narcolepsy is an important example of vaccine induced autoimmunity. An important implication of this result is the impact of vaccines that are ...
According to many observations, certain virus infections may play a part in the autoimmune attack that leads to type 1 diabetes. Researchers at Karolinska Institutet in Sweden and their Finnish colleagues have now produced a vaccine for these viruses in
Interim results of a phase I/II clinical trial of a DNA plasmid vaccine (BHT-3021) for type 1 diabetes Interim results of a phase I/II clinical trial of a DNA plasmid vaccine (BHT-3021) for type 1 diabetesare graphed and the mean change from baseline ......